IFNG and tuberculosis: Screening and prophylactic treatment are key elements to reduce the burden of TB and in many parts of the world, interferon-γ (IFN-γ)-release assays (IGRAs) such as the QuantiFERON-TB Gold Plus (QFT) are used for TBI screening.